Price $179.98 |
Market Cap
38.92B
|
Sector Health Care |
Div. Growth
5.00%
|
|
P/E
24.7
|
P/B
138.21
|
P/S
0.16
|
Dividend %
1.00%
|
|
P/CF
-
|
P/FCF
19.5
|
Op. Cash Flow
2.91M
|
FCF
9.8
|
|
Op. Margin
0.90%
|
Net Margin
0.70%
|
ROE
-
|
ROI
34.50%
|
|
ROA
2.80%
|
EPS Growth
-5.10%
|
Current Ratio
0.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals PLC (JAZZ) | $131.85 | - | - | 7.93B | Strong Buy |
| Paratek Pharmaceuticals Inc (PRTK) | $2.19 | - | - | 126.6M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.10 | - | - | 4.7M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $0.14 | - | - | 12.3M | Strong Buy |
| PAVmed Inc (PAVM) | $0.34 | - | - | 42.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
